IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Supriya Lifescience IPO listing price is ₹ 390.35, issue price is ₹ 274.00, and currently trading at ₹ 687.65 as on July 11, 2025. Supriya Lifescience IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Supriya Lifescience IPO is a Book Building listing on BSE,NSE exchange. The company is based in Mumbai and caters to Pharmaceutical sector. Axis Capital , ICICI Securities are the merchant bankers of Supriya Lifescience IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th May 2021.
Supriya Lifescience IPO offer price is ₹ 274.00 and got listed at ₹ 390.35. Read Supriya Lifescience IPO details mentioned above.The IPO of Supriya Lifescience Limited was listed on 28th December 2021. As of today, Supriya Lifescience IPO is trading at ₹ 687.65, compared to the previous day’s close of ₹ 693.45. Read the report above for detailed IPO performance.
The issue price of Supriya Lifescience IPO was ₹ 274.00 per equity share.
Supriya Lifescience IPO was listed at ₹390.35 on the stock exchange on 28th December 2021. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of July 11, 2025, the current market price of Supriya Lifescience IPO is ₹ 687.65.
The 52-week high for Supriya Lifescience IPO is ₹ 842.00, while the 52-week low is ₹ 368.00. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Supriya Lifescience IPO listed at ₹ 390.35 against the issue price of ₹ 274.00 per equity share, showing a listing day gain/loss of 116.35 (42.46%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Supriya Lifescience IPO stock moved from its listing price of ₹ 390.35 to the current price of ₹687.65 per equity share, reflecting a change of 76.16% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Supriya Lifescience IPO issue date of 28th December 2021 and CMP of ₹687.65, the estimated CAGR is approximately 29.61%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 2
Issue
Price :
₹ 274.00
Listing Price :
₹ 390.35
Previous Day Closing
₹ 693.45
Supriya Lifescience IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Supriya Lifescience Financial Review Page
Merchant Banker(s) of Supriya Lifescience IPO: Axis Capital Limited , ICICI Securities Limited
Supriya Lifescience IPO subscription was 71.51 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Supriya Lifescience IPO listed at a listing price of 390.35 against the offer price of 274.00.
The current market price of Supriya Lifescience is 687.65.
Why Us?
